DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Deployment and use of NGS in Clinical Diagnostics" report to their offering.
Continuous Assessment of the IVD market in Europe from the end user perspective. 2,400 hospital and private laboratories in 8 EU countries (Germany, UK, Italy, France, Spain, Sweden, The Netherlands, and Switzerland) have systematically been surveyed to collect information on the overall test volume and the current and future planned use of NGS including tests and specific volumes.
This report provides highly granular lab based data on market size and competitive landscape. This report is a unique business planning tool that helps to prioritize regional sales activities, define realistic sales targets, keep track of competitor's activities by understanding market shares, identify potential to partner or merge with and compare customer segment performance. dii is an international market research company entirely specialized in diagnostics. The survey has been designed in collaboration with key industry.
Detailed data reports per country with the number of currently installed NGS systems and planned uptake, market shares by installation, separated by lab segment (hospital and independent lab).
For more information about this report visit http://www.researchandmarkets.com/research/2swxkc/deployment_and